Evidence map›Paper›PMID 32517486›Full record

ArticleAntioxidants & redox signaling2020

Neutrophil-Mediated Cardiac Damage After Acute Myocardial Infarction: Significance of Defining a New Target Cell Type for Developing Cardioprotective Drugs.

Mary El Kazzi, Benjamin Saul Rayner, Belal Chami, Joanne Marie Dennis, Shane Ross Thomas, Paul Kenneth Witting

Open access · greenAbstract read
In one paragraph

Article in Antioxidants & redox signaling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances in biomarkers for myocardial injury after non-cardiac surgery.Journal of anesthesia and translational medicine · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Multifaceted roles of neutrophils in cardiac disease.Journal of leukocyte biology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mary El KazziDiscipline of Pathology, Charles Perkins Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Benjamin Saul RaynerThe Heart Research Institute, Sydney, Australia.
Belal ChamiDiscipline of Pathology, Charles Perkins Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Joanne Marie DennisDiscipline of Pathology, Charles Perkins Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Shane Ross ThomasDepartment of Pathology, School of Medical Sciences, The University of New South Wales, Sydney, Australia.
Paul Kenneth WittingDiscipline of Pathology, Charles Perkins Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
The University of Sydney · AUThe Heart Research Institute · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiomarkersCardiotonic AgentsDisease ManagementDisease SusceptibilityHumansLeukocytesMolecular Targeted TherapyMyocardial InfarctionMyocardiumMyocytes, CardiacNeutrophilsOxidative StressPeroxidaseVentricular RemodelingBiomarkersCardiotonic AgentsPeroxidaseischemia reperfusionmyeloperoxidasemyocardial infarctionnitroxides

Identifiers

PMID32517486
PMCPMC7475094
OpenAlexW3032942472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.